DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis

Phase 2

Withdrawn

Conditions: Multiple Sclerosis, Relapsing-Remitting
Fatigue

Interventions: Drug: Placebo
Drug: TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]

First Posted Date: 2021-05-10

Last Posted Date: 2022-11-15

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT04880577

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

Phase 4

Recruiting

Conditions: Gout

Interventions: Drug: Allopurinol
Drug: Naproxen 250 MG
Drug: Colchicine 0.6 mg
Drug: Colchicine 1.2 mg
Drug: Naproxen 500 Mg
Drug: Prednisone 40 mg

First Posted Date: 2021-05-06

Last Posted Date: 2024-09-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 650

Registration Number: NCT04875702

Locations: 🇺🇸
West Virginia University (Including Mobile Clinical Trials Unit), Morgantown, West Virginia, United States
🇺🇸
The University of Alabama at Birmingham, South Birmingham, Alabama, United States
🇺🇸
UCLA Health, Santa Monica, California, United States

and more 4 locations

Seguimos Avanzando - Latino Youth Coping With Discrimination

Completed

Conditions: Mental Health

First Posted Date: 2021-05-06

Last Posted Date: 2024-11-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 886

Registration Number: NCT04875208

Locations: 🇺🇸
University of Notre Dame, William J. Shaw Center for Children and Families, South Bend, Indiana, United States

Mind-body Resiliency Intervention for Fear of Cancer Recurrence

Not Applicable

Completed

Conditions: Cancer
Coping Skills
Coping Behavior

Interventions: Behavioral: Usual Care
Behavioral: IN FOCUS

First Posted Date: 2021-05-06

Last Posted Date: 2023-10-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 64

Registration Number: NCT04876599

Locations: 🇺🇸
Mass General/North Shore Cancer Center, Danvers, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusett General Hospital Cancer Center, Boston, Massachusetts, United States

and more 2 locations

TRANSFORM Heart Failure with Reduced Ejection Fraction

Not Applicable

Withdrawn

Conditions: Heart Failure, Systolic

Interventions: Other: HealthReveal

First Posted Date: 2021-05-05

Last Posted Date: 2024-11-20

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT04872959

Patient Experiences with the COVID-19 Vaccination After Breast Cancer Treatment

Completed

Conditions: Breast Cancer Related Lymphedema
Covid19

Interventions: Other: Survey

First Posted Date: 2021-05-04

Last Posted Date: 2025-01-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 670

Registration Number: NCT04872738

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Gaining Optimism After Weight Loss Surgery (GOALS) II

Not Applicable

Recruiting

Conditions: Bariatric Surgery

Interventions: Behavioral: Positive Psychology-Motivational Interviewing
Behavioral: Physical Activity Education Control

First Posted Date: 2021-04-30

Last Posted Date: 2024-05-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 58

Registration Number: NCT04868032

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Gaining Optimism After Weight Loss Surgery (GOALS) I

Not Applicable

Completed

Conditions: Bariatric Surgery

Interventions: Behavioral: Positive Psychology-Motivational Interviewing Intervention

First Posted Date: 2021-04-30

Last Posted Date: 2023-09-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT04867902

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

Completed

Conditions: Type 2 Myocardial Infarction

First Posted Date: 2021-04-28

Last Posted Date: 2024-03-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT04864119

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Early Phase 1

Recruiting

Conditions: Resectable Hepatocellular Carcinoma
Hepatocellular Carcinoma

Interventions: Drug: Atezolizumab
Drug: Bevacizumab
Radiation: Stereotactic Beam Radiation Therapy (SBRT)

First Posted Date: 2021-04-23

Last Posted Date: 2024-08-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT04857684

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy